The antiinflammatory activity of CVE in Inflammatory Bowel Disease (IBD) might be mediated by the inhibition of signal transducer and activator of transcription (STAT) STAT 1 and STAT 6 in response to IFN-γ and IL-4 expression [14]. This evidence concerns the gene SOAT1 and inflammatory bowel disease.